AZARGA Transition Study in Taiwan for Patients With Uncontrolled Intraocular Pressure
NCT01484951
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
74
Enrollment
INDUSTRY
Sponsor class
Conditions
Glaucoma
Interventions
DRUG:
Brinzolamide 1% and timolol 0.5% fixed combination eye drops
Sponsor
Alcon Research